Incorporation of Orotic Acid into RNA by Liver Tumors
Author Information
Author(s): E. Reid
Primary Institution: Chester Beatty Research Institute, Institute of Cancer Research: Royal Cancer Hospital, London
Hypothesis
How does orotic acid incorporation into ribonucleotides and RNA differ in liver tumors compared to normal liver?
Conclusion
Hepatomas showed a significant decrease in microsomal RNA, while precancerous liver exhibited decreases in RNA across various fractions.
Supporting Evidence
- Hepatomas showed a marked decrease in microsomal RNA.
- Precancerous liver exhibited decreases in RNA in nuclear, mitochondrial, and microsomal fractions.
- RNA labelling was low for nuclear and supernatant fractions in precancerous liver.
Takeaway
This study looked at how a substance called orotic acid gets used in liver tumors and found that tumors use it differently than healthy liver.
Methodology
Rats were injected with [6-14C] orotic acid, and their liver tissues were analyzed for RNA and ribonucleotide levels using differential centrifugation.
Potential Biases
Potential bias due to the use of different batches of orotic acid.
Limitations
The study may not account for variations in absorption rates of the injected precursors.
Participant Demographics
Albino male rats were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website